Ciclosporin eye drops launched for keratitis

The recommended dose of Ikervis is one drop applied to the affected eye(s) once daily at bedtime.
The recommended dose of Ikervis is one drop applied to the affected eye(s) once daily at bedtime.

Further information
View Ikervis drug record
Summary of Product Characteristics
Manufacturer: Santen

Ikervis (ciclosporin) is indicated for the treatment of severe keratitis in adults with dry eye disease that has not improved despite treatment with tear substitutes.

As an immunosuppressant, ciclosporin acts to improve ocular surface damage and reduce inflammation.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Quadruple therapy should be 'new therapeutic standard' for heart failure, say researchers

Quadruple therapy should be 'new therapeutic standard' for heart failure, say researchers

Treatment with a four-drug regimen incorporating newer...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

New guidance for minimising psychological impact of COVID-19 pandemic in primary care patients